Your session is about to expire
← Back to Search
Peripheral Nerve Stimulator
Device Usability for Nerve Injury
N/A
Waitlist Available
Led By Christopher Coroneos, MD
Research Sponsored by Epineuron Technologies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trialwill test a new device to help reduce pain. It will be checked for safety, usability, and effectiveness.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
DASH Questionnaire
Patient Tolerance to Therapy Questionnaire
Semmes-Weinstein Monofilament Test
+1 moreSecondary outcome measures
Device Usability Questionnaire
Safety
Trial Design
2Treatment groups
Experimental Treatment
Group I: Preliminary EfficacyExperimental Treatment1 Intervention
Preliminary treatment efficacy will be evaluated.
Group II: Device UsabilityExperimental Treatment1 Intervention
Device usability and safety will be evaluated.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Temporary Peripheral Nerve Stimulator
2021
N/A
~30
Find a Location
Who is running the clinical trial?
Epineuron Technologies Inc.Lead Sponsor
2 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Nerve Injury
110 Patients Enrolled for Nerve Injury
Christopher Coroneos, MDPrincipal InvestigatorMcMaster University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger